Treatment of lupus nephritis.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006615:Hip; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D051379:Mice; D009336:Necrosis / Q000139:chemically induced; D009393:Nephritis / Q000188:drug therapy* / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone